Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Montoro, Juan  [Clear All Filters]
Journal Article
Piñana JLuis, Rodríguez-Belenguer P, Caballero D, Martino R, López-Corral L, Terol M-J, Vázquez L, Calabuig M, Sanz-Linares G, Marin-Jimenez F, et al. Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients. Ann Hematol. 2022.
Piñana JL, Montoro J, Aznar C, Lorenzo I, Gómez MD, Guerreiro M, Carretero C, González-Barberá EM, Balaguer-Roselló A, Sanz R, et al. The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation. J Infect. 2020.
Solves P, Sanz J, Gómez I, de la Puerta R, Arnao M, Montoro J, Piñana JLuis, Carretero C, Balaguer A, Guerreiro M, et al. Comparison of transfusion requirements in adult patients undergoing haploidentical or single unit umbilical cord blood stem cell transplantation. Eur J Haematol. 2019.
Cantó PAsensi, Mayordomo E, Dorado A, Villalba M, Mañez RBlanco, González E, Salavert M, Facal A, Chorão P, Balaguer A, et al. Disseminated toxoplasma infection after hematopoietic stem cell transplantation with myositis and encephalitis. Transpl Infect Dis. 2023:e14067.
Sanz J, Labopin M, Pabst T, Versluis J, van Gorkom G, Meijer E, Gedde-Dahl T, Montoro J, Arcese W, Pérez-Simón JAntonio, et al. Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party. Bone Marrow Transplant. 2023.
Montoro J, Ceberio I, Hilden P, Maloy MA, Barker J, Castro-Malaspina H, Dahi P, Koehne G, Perales M-A, Ponce D, et al. Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myeloid Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2019.
Balaguer A, Bataller L, Lorenzo I, Jarque I, Salavert M, González E, Piñana JLuis, Sevilla T, Montesinos P, Iacoboni G, et al. Infections of the Central Nervous System Following Unrelated Donor Umbilical Cord Blood Transplantation or HLA-Matched Sibling Transplantation. Biol Blood Marrow Transplant. 2016.
Bueno F, Albert E, Piñana JLuis, Pérez A, Úbeda C, Gómez MDolores, Hernández-Boluda JCarlos, Gonzalez-Barberá EMaría, Montoro J, Giménez E, et al. Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2020:e13507.
Sanz J, Moscardó F, Montoro J, Cano I, Guerreiro M, Dasí MA, Solves P, Lorenzo I, Gómez-Seguí I, Montesinos P, et al. Partial T-cell depleted peripheral blood stem cell transplantation from HLA-identical sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant. 2019.
Piñana JLuis, Giménez E, Gómez MDolores, Pérez A, González EMaría, Vinuesa V, Hernández-Boluda JCarlos, Montoro J, Salavert M, Tormo M, et al. Pulmonary Cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: implications for the diagnosis of CMV pneumonia. J Infect. 2019.
Montoro J, Balaguer-Roselló A, Sanz J. Recent advances in allogeneic transplantation for acute myeloid leukemia. Curr Opin Oncol. 2023;35(6):564-573.
Balaguer-Roselló A, Gil-Perotín S, Montoro J, Bataller L, Lamas B, Villalba M, Facal A, Guerreiro M, Chorão P, Bataller A, et al. Reduced incidence of neurologic complications after allogeneic hematopoietic stem cell transplantation with calcineurin-free graft-versus-host disease prophylaxis. Transplant Cell Ther. 2023.
Piñana JLuis, López-Corral L, Martino R, Vázquez L, Pérez A, Martin-Martin G, Gago B, Sanz-Linares G, Sanchez-Salinas A, Villalon L, et al. SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders. J Hematol Oncol. 2022;15(1):54.
Piñana JLuis, López-Corral L, Martino R, Montoro J, Vázquez L, Pérez A, Martin-Martin G, Facal-Malvar A, Ferrer E, Pascual M-J, et al. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Am J Hematol. 2021.
Chorão P, Montoro J, Balaguer-Roselló A, Guerreiro M, Villalba M, Facal A, Solves P, Gómez-Seguí I, Pasquini MC, Granados P, et al. T-cell Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia. Transplant Cell Ther. 2023.
Rafii H, Volt F, Bierings M, Dalle J-H, Ayas M, Rihani R, Faraci M, de Simone G, Sengeloev H, Passweg J, et al. Umbilical Cord Blood Transplantation for Fanconi Anemia with a special focus on late complications: a Study on Behalf of Eurocord and SAAWP-EBMT. Transplant Cell Ther. 2024.
Rodríguez-Veiga R, Montesinos P, García E, Boluda B, Rojas R, Serrano J, Martínez-Cuadrón D, Martín C, Sanz J, Tabares S, et al. Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients. Mycoses. 2019.
Sanz J, Labopin M, Choi G, Kulagin A, Peccatori J, Vydra J, Remenyi PPal, Versluis J, Rovira M, Blaise D, et al. Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT. Blood. 2024.